IR@PKUHSC  > 北京大学第一临床医学院
学科主题临床医学
Integration of Traditional Chinese Medicines and Western Medicines for Treating Diabetes Mellitus with Coronary Heart Disease: A Systematic Review
Li, Wei-Wei1; Guo, Hao2; Li, Hong-Hao3; Wang, Lin-Lin1; Fu, Hong1; Wang, Xue-Mei1
刊名JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE
2013-06-01
DOI10.1089/acm.2012.0568
19期:6页:492-500
收录类别SCI
文章类型Review
WOS标题词Science & Technology
类目[WOS]Integrative & Complementary Medicine
研究领域[WOS]Integrative & Complementary Medicine
关键词[WOS]QUALITY ; TRIALS
英文摘要

Purpose: Diabetes mellitus with coronary heart disease (DM with CHD) poses a health challenge to people in China and elsewhere in the world. In Traditional Chinese Medicine (TCM), DM with CHD is classified as a type of disease called Xiaoke and Xiongbi. In Asia, TCM has been used to treat Xiaoke and Xiongbi conditions for centuries, especially in China. In this study, it was evaluated whether integrated strategies incorporating both TCM and Western medicines (iTCWM) could improve the curative efficacy of DM with CHD.

Methods: An extensive search for randomized clinical trials (RCTs) published up to November 2011 in either English or Chinese about iTCWM for DM with CHD was conducted. All listings in PubMed, EMBASE, the Cochrane Library, CBM, CNKI, VIP, and the Wanfang database were included in the literature search. The quality of each trial was assessed using the Cochrane Reviewers′ Handbook 5.0. Data analysis was performed by the RevMan 5.0 provided by the Cochrane Collaboration.

Results: After an initial selection of 207 articles, 21 RCTs and quasi-RCTs were ultimately included in the analysis for this study. All of these trials were conducted in China and published in Chinese journals. The methodological quality of the trials was low in most studies. Selection bias and measurement bias were common in all of the studies. A meta-analysis was not conducted, due to the poor quality of the available studies.

Conclusions: The current state of the literature regarding the utility of iTCWM for the treatment of DM with CHD is inadequate. The poor quality of the available trials makes it difficult to draw any conclusions regarding the efficacy of iTCWM for the treatment of DM with CHD. This study highlights the paucity of reliable clinical evidence for iTCWM and the need for higher quality RCTs to be conducted in the future.

语种英语
WOS记录号WOS:000319909800002
项目编号81102683 ; 30973813 ; 20110001120055
资助机构National Natural Science Foundation of China ; Ministry of Education of China
引用统计
被引频次:5[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/50693
专题北京大学第一临床医学院
北京大学第一临床医学院_中医中西医结合科
作者单位1.Peking Univ, Hosp 1, Inst Integrated Chinese & Western Med, Beijing 100034, Peoples R China
2.Tianjin Univ Tradit Chinese Med, Minist Educ, Key Lab Pharmacol Tradit Chinese Med Formulae, Tianjin, Peoples R China
3.Hunan Agr Univ, Lib Hunan Agr Univ, Changsha, Hunan, Peoples R China
推荐引用方式
GB/T 7714
Li, Wei-Wei,Guo, Hao,Li, Hong-Hao,et al. Integration of Traditional Chinese Medicines and Western Medicines for Treating Diabetes Mellitus with Coronary Heart Disease: A Systematic Review[J]. JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE,2013,19(6):492-500.
APA Li, Wei-Wei,Guo, Hao,Li, Hong-Hao,Wang, Lin-Lin,Fu, Hong,&Wang, Xue-Mei.(2013).Integration of Traditional Chinese Medicines and Western Medicines for Treating Diabetes Mellitus with Coronary Heart Disease: A Systematic Review.JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE,19(6),492-500.
MLA Li, Wei-Wei,et al."Integration of Traditional Chinese Medicines and Western Medicines for Treating Diabetes Mellitus with Coronary Heart Disease: A Systematic Review".JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE 19.6(2013):492-500.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Li, Wei-Wei]的文章
[Guo, Hao]的文章
[Li, Hong-Hao]的文章
百度学术
百度学术中相似的文章
[Li, Wei-Wei]的文章
[Guo, Hao]的文章
[Li, Hong-Hao]的文章
必应学术
必应学术中相似的文章
[Li, Wei-Wei]的文章
[Guo, Hao]的文章
[Li, Hong-Hao]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。